Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density

Kaunitz, Andrew M., Darney, Philip D., Ross, Douglas, Wolter, Kevin D., Speroff, Leon·2009·Contraception

Cited by (122)

Items 101–122 of 122

  1. Avaliação dos efeitos toxicológicos do dimetoato e dimetoato nanoencapsulado em "Danio rerio" (Zebrafish)
    J. H. Vallim · 2019
  2. Self-Administered Subcutaneous Medroxyprogesterone Acetate for Improving Contraceptive Outcomes: A Systematic Review and Meta-Analysis
    Ashraf Fawzy Nabhan, Amal Elshabrawy, Farida Elshafeey, Luna Marion Mehrain, Rita Kabra · 2021 · Research Square
  3. Hormonale Optionen jenseits der Pille
    Hans-Joachim Ahrendt · 2012 · gynäkologie + geburtshilfe
  4. Contraception in general practice: Frequently asked questions
    Carol Marilyn Ann Robinson · 2016 · Practice Nursing
  5. Family Planning Services and Birth Control
    Jessica Elizabeth Morse, Philip D. Darney · 2013
  6. Abnormal Uterine Bleeding
    Raj Narayan, Benjamin D. Beran · 2020 · Springer eBooks
  7. Contraceptive Effectiveness
    Michael S. Awadalla · 2020 · Springer eBooks
  8. Contraceptive Effectiveness
    Crystal Goldsmith · 2015 · Springer eBooks
  9. Progestogen-Only Contraception
    Frans J.M.E. Roumen, Gabriele S. Merki‐Feld, Katarina Sedlecky · 2024 · Cambridge University Press eBooks
  10. Hormonale Kontrazeption
    Inka Wiegratz · 2024 · Springer eBooks
  11. Common menstrual concerns in the adolescent
    Nancy A. Sokkary, Oluyemisi Adeyemi‐Fowode · 2024 · Elsevier eBooks
  12. Data pharmacovigilance analysis of medroxyprogesterone-related adverse events in the FDA adverse event reporting system
    Xiaomeng Wang, Jimei Wang, Fang Liu, Kexin Zhang, Min Zhao, Lin Xu · 2025 · Expert Opinion on Drug Safety
  13. Menstrual Suppression in Adolescents
    Corey S. Bolac, Jennifer O. Howell · 2025 · Obstetrical & Gynecological Survey
  14. Differenzierte Kontrazeptionsberatung – Was ist zu beachten?
    Thomas Römer · 2025 · Die Gynäkologie
  15. Return to fertility after subcutaneous depot medroxyprogesterone acetate: a narrative review
    Alfred Onyango Osoti, Nancy Kidula, Lauryn Mengesa, James Njogu Kiarie · 2025 · BMJ Sexual & Reproductive Health
  16. Additional file 1 of Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis
    Nabhan, Ashraf, Farida Elshafeey, Luna Marion Mehrain, Rita Kabra, Amal Elshabrawy · 2021 · Figshare
  17. Comparative Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women Living With HIV on Dolutegravir‐Based Antiretroviral Therapy
    Katie R. Mollan, Brian W. Pence, Daniel J. Westreich, Agatha Kapatuka Bula, Clara Lemani, John Chawezi Chapola, Sam Phiri, Jane Chiwoko, Michael G. Hudgens, Lameck Chinula et al. · 2026 · Pharmacoepidemiology and Drug Safety
  18. Contraceptive Implants and Injectables
    Luis Guillermo Bahamondes, Cassia Teatin Juliato, M. Valeria Bahamondes · 2026 · Reproductive medicine for clinicians
  19. A randomized, dose-range finding study to evaluate the pharmacokinetics of medroxyprogesterone acetate following subcutaneous administration of TV-46046
    Vera Halpern, Douglas J. Taylor, Vivian Brache, Angie Wheeless, Paula Hines, Maria R. Fawzy, Laneta J. Dorflinger · 2026
  20. From Awareness to Autonomy: Exploring the Knowledge Gap and Acceptability of Self-Injectable DMPA-SC among Women in Central India
    Anita Yadav, Anusha Kamath, Jyoti Baghel, Neha Gangane, Amruta Choudhary, Shuchita Ramesh Mundle · 2026 · Indian Journal of Community Medicine
  21. Contraception for transgender and gender diverse people
    Alessandra Lami, Manuela Farris, Maria Cristina Meriggiola · 2026 · The European Journal of Contraception & Reproductive Health Care
  22. Estudo prospectivo da densiometria ossea do antebraço em usuarios de longo tempo do sistema intrauterino liberador de levonorgestrol (SIU-LNG)
    Maria Valeria Bahamondes Makuch · 2006